Pregnancy outcome after mechanical mitral valve replacement: A prospective study

Journal of Tehran University Heart Center

Volumn 7, Issue 3, 2012, Pages 117-120

  Samiei, Niloufar ^a   Kashfi, Fahimeh ^a,b   Khamoushi, Amirjamshid ^a   Hosseini, Saeid ^a   Ghavidel, Alireza Alizadeh ^a   Taheripanah, Robabeh ^c   Mirmesdagh, Yalda ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticoagulants; Heart valve prosthesis; Pregnancy

Indexed keywords

HEPARIN; WARFARIN;

ABORTION; ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FETUS; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; MITRAL VALVE PROSTHESIS; MITRAL VALVE REPLACEMENT; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PROSTHETIC VALVE THROMBOSIS; STILLBIRTH;

EID: 84872318451     PISSN: 17358620     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Danik S, Fuster V. Anticoagulation in pregnant women with prosthetic heart valves. Mt Sinai J Med 2004 71:322-329.
2. Marcus-Braun N, Segal D, Merkin M, wiziter A, Katz M, Tager S, Llya R, Mazor M. Anticoagulation in pregnant women with prosthetic heart valve - a new approach for therapy. Harefuah 2003;142:508-511.
3. Grun kemeier GL, Starr A, Rahimtoola SH. Chinical performance of prosthetic heart valves. In: Fuster V, Alexander RW, O'Rourke RA, eds. The Heart. I0'h ed. New York: McGraw-Hill; 2001. p. 1759-1774.
4. Bron D, Martines EE, Almeida PA, Santos DV, Carvalho AC, Moron AF, Miyasaki CH, Moraes SD, Ambrose JA. Pregnancy in patient with prosthetic heart valves the effect of anticoagulation on mother, fetus and neonatal. Am Heart J 1992;124:413-417.
5. Elkayam U, Bitar F. Valvular heart disease and pregnancy: Part II: Prosthetic valves. J Am Coll Cardiol 2005;46:403-410.
6. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomenon in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 1996 22:1698-1703.
7. Shannon MS, Edwards MB, Long F, Taylor KM, Bagger JP, De Swiet M. Anticoagulant management of pregnancy following heart valve replacement in the United Kingdom 1986-2002. J Heart Valve Dis 2008 17:526-532.
8. Akhtar RP, Abid AR, Zafar H, Cheema MA, Khan JS. Anticoagulation in pregnancy with mechanical heart valves: 10-year experience. Asian Cardiovasc Thorac Ann 2007; 15:497-501.
9. Geelani MA, Singh S, Verma A, Nagesh A, Betigeri V, Nigam M. Anticoagulation in patients with mechanical valves during pregnancy. Asian Cardiovasc Thorac Ann 2005;13:30-33.
10. Nassar AH, Hobeika EM, Abd Essamad HM, Taher A, Khalil AM, Usta IM. Pregnancy outcome in women with prosthetic heart valves. Am J Obstet Gynecol 2004;191:1009-1013.
11. Maxwell C, Sermer M. Mechanical heart valves and pregnancy. Fetal Matern Med Rev 2007; 18:311 -331.
12. Maxwell C V, Poppas A, Dunn E, Sermer M. Pregnancy, mechanical heart valves and anticoagulation: navigating the complexities of management during gestation. In: Rosene-Montella K, Keely EJ, Barbour LA, Lee RV, eds. Medical Care of the Pregnant Patient. 2nd ed. Philadelphia: American College of Physicians; 2007. p. 344-355.
13. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society ofThoracic Surgeons, Bonow RO, Carabello BA, Kanu C, de Leon AC, Jr, Faxon DP, Freed MD, Gaasch WH, LytleBW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society ofThoracic Surgeons. Circulation 2006;114:e84-231.
14. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637-1641.
15. Khamooshi AJ, Kashfi F, Hosseini S, Tabatabaei MB, Javadpour H, Noohi F. Anticoagulation for prosthetic heart valves in pregnancy. Is there an answer? Asian cardiovasc Thorac Ann 2007; 15:493-496.
16. Khamoushi AJ, Kashfi F, Hosseini S, Alizadeh Ghavidel AR, Samiei N, Haddadzadeh M. Anti-coagulation During Pregnancy in women with mechanical heart valves: A prospective study IJFS 2011;5:47-51.
17. Warnes CA. Prosthetic heart valves. In: Steer PJ, Gatzoulis MA, Baker P, eds. Heart Disease and Pregnancy. London: RCOG Press; 2006. p. 157-168.